POC studies should be well-designed for an efficient trade-off analysis and to inform promoters on go/no-go rules. We promote the leveraging of fast-evolving scientific knowledge to shorten the development cycle and address unmet needs in a more efficient way.
chevron_rightHealth Technology Assessment
HTA is getting more complex, detailed, and sophisticated to inform health plans and/or governments on the opportunities for funding. There is a trend towards a more in-depth clinical effectiveness and economic analysis far beyond the classical guideline endorsement or cost per QALY calculation. It is more challenging for promoters to navigate among these conflicting requests.
Sir William Osler once said to study medicine without books is to sail an uncharted sea; while to study medicine only from books is not to go to sea at all.
Medi-Qualité Omega advocates that to approach HTA without a robust academic, clinical, and economic knowledge is to sail an uncharted sea; whilst to keep your practice of HTA theoretical is not to go to sea at all.
At the end of the 20th century, we witnessed a substantial improvement in life expectancy with and without good quality of life. However, during the last two decades, the improvement in life expectancy associated with a good quality of life has almost plateaued. As a result, researchers from life sciences and IT domains, have been challenged to reduce the gap between life expectancy in good health and death. Therefore, the focus of the industry is now increasingly aimed at in-depth remission or even, complete cure. The spotlight is on the elderly, as well as on children with orphan conditions still suffering from many chronic illnesses without a cure at sight. We strongly believe that the merge between life sciences, mathematics, and computing will help to shrink long-term disabilities in the next few decades.
Promoters are increasingly challenged across the globe to satisfy the requirements of conflicting stakeholders and perspectives. Now more than ever, there is a need for strategic and outside-the-box thinking that goes beyond the classical geographic sequencing to re-challenge clinical and economic perspectives and values.